TotalEnergies sells half of Portuguese renewable assets but remains operator

Jacques Aschenbroich Lead Independent Director of TotalEnergies TotalEnergies SE
Jacques Aschenbroich Lead Independent Director of TotalEnergies - TotalEnergies SE
0Comments

Paris, July 2, 2025 – TotalEnergies has announced the sale of 50% of its renewable energy portfolio in Portugal. The assets, comprising wind, solar, and hydroelectric facilities totaling 604 MW, have been sold to a consortium including MM Capital Partners 2 Co., Ltd., Daiwa Energy & Infrastructure Co. Ltd., and Mizuho Leasing Co., Ltd. The transaction is valued at €178.5 million, equating to an enterprise value of €550 million.

TotalEnergies will retain a 50% stake in the portfolio and continue operating the assets. After the expiration of current regulated tariffs, TotalEnergies plans to purchase and commercialize the energy produced by these assets, which are on average 16 years old.

Olivier Jouny, SVP Renewables at TotalEnergies, commented on the deal: “We are pleased with this partnership in Portugal, a country where TotalEnergies intends to continue its development in renewables. In line with our strategy, this transaction allows us to optimize our capital allocation in our integrated electricity activities and contribute to improving the sector’s profitability.”

TotalEnergies is working towards building a competitive energy portfolio that combines renewables such as solar and wind power with flexible assets like storage solutions. By March 2025, TotalEnergies had achieved an installed gross renewable electricity generation capacity of 28 GW and aims for 35 GW by year-end. The company targets more than 100 TWh of net electricity production by 2030.

The multinational energy company is committed to offering reliable and sustainable energy solutions globally through various sources including oil, biofuels, natural gas, biogas, low-carbon hydrogen, renewables, and electricity.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.